SUMMARY In three out of five patients with low cerebrospinal fluid thiamine concentrations, the 5-hydroxyindoleacetic acid (5HIAA) values also were low. All patients received thiamine replacement therapy; they underwent a second lumbar puncture after 13, 6, 7, 5 and 45 days of treatment. In all patients blood and cerebrospinal fluid thiamine values rose after treatment. In those patients with initially low CSF 5HIAA, thiamine treatment increased 5HIAA markedly.
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Thiamine deficiency is associated with an impairment of 5-hydroxytryptamine (5HT) neurons in experimental animals.' In rats, a long-lasting folate deficiency can induce a secondary thiamine deficiency2 and some of the behavioural changes in these animals can be reversed by administration of high doses of thiamine.3 Recently we have reported4 that folate deficient patients, who exhibit a folateresponsive neuropyschiatric syndrome have low levels of the 5HIAA in their cerebrospinal fluid (CSF) . Low values of CSF 5-hydroxyindoleacetic acid (5HIAA) were also reported in patients with inborn errors of folate metabolism.5 We now wish to report on CSF 5HIAA levels in a small group of thiamine deficient patients before and after thiamine supplementation. To our knowledge, this is the first study on the correlations between thiamine and 5HIAA in the human CSF.
Methods and Patients
Five patients were studied. Blood and CSF were taken before and after thiamine replacement therapy, for the measurement of blood and CSF thiamine, serum and CSF folate, and CSF tryptophan and 5HIAA levels. Blood and CSF samples were collected at 9.00-9.30 a.m. The last lumbar puncture. The whole blood and CSF thiamine levels were assayed in duplicate, using Lactobacillus ferment.6 When low values of thiamine were found, an additional incubation was carried out with added thiamine to check that no inhibitors of bacterial growth were present.7
The 7 Control values* (mean ± SD) (table) . The mean pretreatment CSF 5HIAA for the folate deficient patients (7.6 ng/ml) was less than control values (p < 0005, two-tailed Student's t test). Pretreatment CSF 5HIAA values were low (below mean-2 x SD of controls) in three out of five patients (nos 3-5). In these three patients thiamine treatment increased CSF 5HIAA markedly and the largest rise was seen in the patient no 5 who had been treated for the longest time with thiamine.
Discussion
The changes in CSF 5HIAA values appeared to result from thiamine treatment and not from some other nutritional factors because the dietary habits were not modified during the thiamine replacement therapy, and because the serum and CSF folate values (except case no 1), as well as the CSF tryptophan levels, did not differ significantly in the whole group before versus after thiamine therapy.
Our data suggest that thiamine deficiency can decrease 5HT metabolism in human by an unknown mechanism that can be reversed by thiamine supplementation. However, two of the five patients had normal 5HIAA values which were only increased minimally by thiamine supplementation. This suggests that thiamine deficiency alone does not necessarily impair brain 5HT metabolism in so far as this is indicated by CSF 5HIAA values.
The last point to be stressed is that patient no 5 who had been treated with phenytoin had low CSF 5HIAA values and low blood and CSF thiamine levels. In previous studies3 14 we found. abnormally low thiamine values in both whole blood and CSF in phenytoin-treated epileptics. One of us (MIB unpublished observations) studied recently two other cases of chronic PHT-induced cerebellar ataxia with low blood and CSF thiamine values. Therefore this study raises some important questions for future research namely: (1) to what extent is the phenytoin-induced chonic cerebellar ataxia"5 correlated with a lowering of thiamine levels?; (2) what is the mechanism by which phenytoin usually lowers the levels of CSF 5HIAA16; is -this mechanism correlated with folate deficiency, with thiamine deficiency or with both? Further studies are needed in both humans (epileptic and non-epileptic patients) and animals to verify to what extent the disturbed serotonin metabolism is correlated not only with folate values as has been already emphasised'6 17 but also with thiamine metabolism. 
